The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer.
 
Mitchell E. Gross
Consulting or Advisory Role - Amgen; BeiGene; Jazz Pharmaceuticals; ReoLab
Research Funding - Clovis Oncology; GlaxoSmithKline; Janssen Biotech (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen
 
David B. Agus
Leadership - Olive AI; Project Ronin; Sensei Biotherapeutics; Thrive Global
Stock and Other Ownership Interests - Color genomics; Olive AI; Project Ronin; Sensei Biotherapeutics; Tempus; Thrive Global
Consulting or Advisory Role - Color Genomics; Tempus
 
Tanya B. Dorff
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Oncology; Noxopharm; Roche; Seagen
Speakers' Bureau - Exelixis; Prometheus
Research Funding - Bayer; Bristol-Myers Squibb
 
Jacek K. Pinski
No Relationships to Disclose
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Genentech/Roche; Janssen Oncology; Merck Sharp & Dohme; Mundipharma; Novartis; Pfizer; Pharmacyclics; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; Exelixis; Genentech/Roche; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi; Seagen; US Biotest
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb Japan; Exelixis; Merck; Roche
(OPTIONAL) Uncompensated Relationships - Eisai; US Biotest
 
Olga O. Castellanos
No Relationships to Disclose
 
Patrick O. Gilmore
No Relationships to Disclose
 
Jean Shih
No Relationships to Disclose